Palvella Therapeutics PVLA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$15.77M-92.6% | -$12.71M-110% | -$11.35M-293% | -$9.47M-164% | -$8.19M-223% | ||
| $3.38M+209% | $2.08M+678% | $1.79M+799% | $1.43M+560% | $1.09M+649% | ||
| $851K-24.3% | $1.16M+2,588% | —— | $116K-72.7% | $1.12M+1,222% | ||
| -$900K+69.1% | —— | —— | —— | -$2.91M-1,117% | ||
| $357K+144% | -$222K-118% | -$182K-236% | -$141K-187% | -$819K-1,417% | ||
| —— | —— | —— | —— | —— | ||
| -$49K— | —— | —— | —— | $0— | ||
| -$10.86M-60.5% | -$4.93M+8.7% | -$7.88M-187% | -$5.43M-239% | -$6.77M-514% | ||
| -$55.44M— | —— | —— | —— | $0-100% | ||
| $230M— | $105K— | $242K— | $416K— | $0— | ||
| $1.98M— | —— | —— | —— | $0— | ||
| $14.25M— | —— | —— | —— | $0— | ||
| $214.73M+17,964% | -$49K-100% | —— | —— | -$1.2M— | ||
| -$15K-150% | —— | $770K— | -$108K— | -$6K— | ||
| $148.41M+1,961% | -$5.59M-108% | -$6.87M— | -$5.19M-163% | -$7.98M-624% | ||
| $15K— | —— | —— | —— | $0— | ||
| $851K-24.3% | $1.16M+2,588% | —— | $116K-72.7% | $1.12M+1,222% | ||
| -$900K+69.1% | —— | —— | —— | -$2.91M-1,117% | ||
| $116K+54.7% | $119K-48.0% | $82K+9.3% | $118K-56.5% | $75K+29.3% | ||
| -$49K— | —— | —— | —— | $0— | ||
| $357K+144% | -$222K-118% | -$182K-236% | -$141K-187% | -$819K-1,417% | ||
| —— | $38.5K— | $38.5K— | $38.5K— | $38.5K— | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| -$49K— | —— | —— | —— | $0— | ||
| —— | -$526.25K-206% | -$526.25K-206% | -$526.25K-206% | -$526.25K-206% | ||
| $44K— | —— | —— | —— | $0— | ||
| $2.04M+67.8% | —— | —— | —— | $1.22M+25.0% | ||
| $1.98M— | —— | —— | —— | $0— | ||
| $0-100% | —— | —— | —— | $1.27M— | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Palvella Therapeutics generate?
- Palvella Therapeutics (PVLA) generated -$29.1M in operating cash flow over the trailing twelve months.
- What is Palvella Therapeutics's free cash flow?
- Palvella Therapeutics's free cash flow was -$15.2M over the trailing twelve months, up 67.1% year over year.
- Where does Palvella Therapeutics's cash flow data come from?
- Every line is extracted from Palvella Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
